高压氧治疗对老年冠心病不稳定型心绞痛患者血脂代谢及血管炎症因子的影响
CSTR:
作者:
作者单位:

(1.邢台市中心医院 心血管内科,河北 邢台 054000;2.邢台市中心医院 药剂科,河北 邢台 054000)

作者简介:

通讯作者:

中图分类号:

基金项目:

邢台市重点研发计划自筹项目(2023ZC098)


Influence of hyperbaric oxygen therapy on blood lipid metabolism and vascular inflammatory factors in elderly coronary heart disease patients with unstable angina
Author:
Affiliation:

(1.Department of Cardiology, Xingtai 054000, Hebei Province, China;2.Department of Pharmacy, Xingtai Central Hospital, Xingtai 054000, Hebei Province, China)

Fund Project:

This work was supported by the Self-Funded Project of Key Research and Development Plan of Xingtai (2023ZC098).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨高压氧治疗(HBOT)在缓解老年冠心病不稳定型心绞痛(UA)患者临床症状中的价值,并探讨其对患者外周血D-二聚体(D-D)、血脂代谢及血管炎症因子的影响。方法 选择邢台市中心医院2021年6月至2023年12月收治的146例老年冠心病UA患者为研究对象,根据随机数表法将患者分为HBOT组(HBOT+基础治疗,n=73)和对照组(基础治疗,n=73),两组患者均连续干预15d。比较两组患者的治疗效果及治疗前后外周血D-D、血脂代谢、血管炎症因子[高敏C反应蛋白(hs-CRP)、血脂蛋白相关磷脂酶A2(Lp-PLA2)、同型半胱氨酸(Hcy)]水平,同时统计两组患者入院第2天及出院前1d心绞痛发生次数及持续时间。采用SPSS 26.0统计软件进行数据处理,根据数据类型分别采用t检验或χ2检验进行组间比较。结果 HBOT组中6例患者因HBOT适应差及高压氧治疗费用问题退出,剩余67例配合完成15d的治疗;对照组患者均配合完成15d治疗。治疗后,HBOT组血脂代谢指标TG及血浆D-D水平较同组治疗前下降、HDL-C水平较治疗前升高,且HBOT组血浆D-D水平低于对照组,HDL-C水平高于对照组,差异有统计学意义(P<0.05);对照组治疗后血脂代谢指标及血浆D-D水平无明显改善,差异无统计学意义(P>0.05)。治疗后,两组患者血管炎症因子hs-CRP、Lp-PLA2及Hcy水平均较同组治疗前下降;出院前1d,两组日均心绞痛发作次数及心绞痛持续时间均较同组入院第2天下降;HBOT组治疗后血管炎症因子水平、日均心绞痛发作次数及持续时间均显著低于对照组,差异有统计学意义(P<0.05)。HBOT组患者治疗有效率显著高于对照组[92.54%(62/67)和80.82%(59/73)],差异有统计学意义(P<0.05)。结论 HBOT在减少UA发作次数及心绞痛持续时间中具有良好的功效,除传统作用机制外,HBOT还可能通过减少血管炎症因子释放、改善血脂代谢紊乱及血液高凝状态,发挥治疗效果。

    Abstract:

    Objective To explore the value of hyperbaric oxygen therapy (HBOT) on relieving the clinical symptoms in elderly coronary heart disease (CHD) patients with unstable angina (UA), and to investigate its impact on peripheral blood D-dimer (D-D), blood lipid metabolism and vascular inflammatory factors. Methods A total of 146 elderly CHD patients with UA admitted to our hospital from June 2021 to December 2023 were recruited and randomly divided into HBOT group (HBOT+ basic treatment, n=73) and control group (basic treatment, n=73). Both groups of patients were continuously intervened for 15 d. The therapeutic effect, as well as peripheral blood levels of D-D, blood lipids and vascular inflammatory factors [high-sensitivity C-reactive protein (hs-CRP), lipoprotein-associated phospholipase A2 (Lp-PLA2), homocysteine (Hcy)] before and after treatment were determined and compared between two groups. The frequency and duration of angina pectoris on the second day after admission and on the first day before discharge were counted in both groups. SPSS 26.0 was used for data analysis, and t test or χ2 test was carried out depending on data type. Results In the HBOT group, six patients withdrew due to poor adaptation to HBOT treatment and cost of HBOT, and the remaining 67 patients completed 15 d of treatment. All the patients in the control group completed 15 d of treatment. After treatment, the levels of blood lipids, TG and plasma D-D in the HBOT group were decreased than the levels before treatment, while the HDL-C was enhanced than the levels before treatment; the plasma D-D were significantly lower while the HDL-C were significantly higher in the HBOT group than the control group (P<0.05). The levels of blood lipid indicators and plasma D-D in the control group were not notably improved after treatment (P>0.05). After treatment, the levels of vascular inflammatory factors hs-CRP, Lp-PLA2 and Hcy were decreased in both groups, and the average daily frequency of angina pectoris attacks and duration of angina pectoris in both groups were reduced on the first day before discharge compared with those on the second day after admission. The levels of vascular inflammatory factors and average daily frequency and duration of angina pectoris attacks were significantly lower in the HBOT group than the control group after treatment (P<0.05). The effective rate of treatment was significantly higher in the HBOT group than the control group [92.54% (62/67) vs 80.82% (59/73), P<0.05]. Conclusion HBOT has good efficacy in reducing the frequency of angina pectoris attacks and the duration of angina pectoris. Besides the traditional mechanism, HBOT may also play a therapeutic effect by reducing the releases of vascular inflammatory factors and improving the lipid metabolism disorder and hypercoagulable state.

    参考文献
    相似文献
    引证文献
引用本文

田玉,牛彦雪,乔香玲,赵海川.高压氧治疗对老年冠心病不稳定型心绞痛患者血脂代谢及血管炎症因子的影响[J].中华老年多器官疾病杂志,2025,24(6):446-450
DOI:10.11915/j. issn.1671-5403.2025.06.093

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-06-19
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-06-25
  • 出版日期:
文章二维码